{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:34:47Z","timestamp":1775349287680,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pathology North Immunology Trust Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.humimm.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T22:07:18Z","timestamp":1471903638000},"page":"1140-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine \u2013 Induced Stevens-Johnson syndrome\/Toxic Epidermal Necrolysis in individuals of Asian ancestry"],"prefix":"10.1016","volume":"77","author":[{"given":"Dinh Van","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hieu Chi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nga Thi Quynh","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu Thi Linh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong Thi Minh","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamma","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suran L.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.humimm.2016.08.010_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2011.05.003","article-title":"Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study","volume":"96","author":"Hsieh","year":"2011","journal-title":"Epilepsy Res."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2016.08.010_b0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2011.02.012","article-title":"Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population","volume":"95","author":"Landmark","year":"2011","journal-title":"Epilepsy Res."},{"issue":"19","key":"10.1016\/j.humimm.2016.08.010_b0015","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"6982","key":"10.1016\/j.humimm.2016.08.010_b0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humimm.2016.08.010_b0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","article-title":"Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China","volume":"19","author":"Wu","year":"2010","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.humimm.2016.08.010_b0030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.humimm.2016.08.010_b0035","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","article-title":"Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients","volume":"67","author":"Zhang","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.humimm.2016.08.010_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11596-014-1247-7","article-title":"Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China","volume":"34","author":"Sun","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"4","key":"10.1016\/j.humimm.2016.08.010_b0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"issue":"Suppl. 7","key":"10.1016\/j.humimm.2016.08.010_b0050","first-page":"16","article-title":"Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study","volume":"20","author":"Kwan","year":"2014","journal-title":"Hong Kong Med. J."},{"issue":"12","key":"10.1016\/j.humimm.2016.08.010_b0055","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.humimm.2016.08.010_b0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.humimm.2016.08.010_b0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"2","key":"10.1016\/j.humimm.2016.08.010_b0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population","volume":"50","author":"Chang","year":"2011","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.humimm.2016.08.010_b0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/archdischild-2013-304767","article-title":"Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore","volume":"99","author":"Chong","year":"2014","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.humimm.2016.08.010_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5415\/apallergy.2015.5.2.68","article-title":"HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese","volume":"5","author":"Nguyen","year":"2015","journal-title":"Asia Pac. Allergy"},{"issue":"3","key":"10.1016\/j.humimm.2016.08.010_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharmacogenomics J."},{"issue":"12","key":"10.1016\/j.humimm.2016.08.010_b0090","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.humimm.2016.08.010_b0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.humimm.2016.08.010_b0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.humimm.2016.08.010_b0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"12","key":"10.1016\/j.humimm.2016.08.010_b0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.humimm.2016.08.010_b0115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.1016\/j.humimm.2016.08.010_b0120","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1373\/clinchem.2009.127894","article-title":"New testing approach in HLA genotyping helps overcome barriers in effective clinical practice","volume":"55","author":"Cheng","year":"2009","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.humimm.2016.08.010_b0125","doi-asserted-by":"crossref","first-page":"e0155907","DOI":"10.1371\/journal.pone.0155907","article-title":"Comparison of a new in-house and three published HLA-B*15:02 screening methods for prevention of carbamazepine-induced severe drug reactions","volume":"11","author":"Jaruthamsophon","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.humimm.2016.08.010_b0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1399-0039.2012.01836.x","article-title":"A nested sequence-specific primer-polymerase chain reaction for the detection of HLA-B*15:02","volume":"79","author":"Virakul","year":"2012","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.humimm.2016.08.010_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.humimm.2016.08.010_b0140","doi-asserted-by":"crossref","first-page":"D1222","DOI":"10.1093\/nar\/gks949","article-title":"The IMGT\/HLA database","volume":"41","author":"Robinson","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.humimm.2016.08.010_b0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"Koressaar","year":"2007","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.humimm.2016.08.010_b0150","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3-new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.humimm.2016.08.010_b0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-0039.1998.tb03041.x","article-title":"Typing of HLA-B*15 alleles using sequence-specific primers","volume":"52","author":"Yu","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2016.08.010_b0160","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net, Update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"21\u201322","key":"10.1016\/j.humimm.2016.08.010_b0165","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.cca.2011.07.003","article-title":"A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources","volume":"412","author":"Badulli","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.humimm.2016.08.010_b0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/pgs.13.242","article-title":"Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data","volume":"15","author":"Dello Russo","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.humimm.2016.08.010_b0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0039.2007.00982.x","article-title":"HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam","volume":"71","author":"Hoa","year":"2008","journal-title":"Tissue Antigens"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T03:20:20Z","timestamp":1536463220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916304190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0198885916304190"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.08.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine \u2013 Induced Stevens-Johnson syndrome\/Toxic Epidermal Necrolysis in individuals of Asian ancestry","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}